NASDAQ:KYTX | Income Statement | Kyverna Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$24.79M$39.56M-$39.56M$1.24M-$38.32M-$0.63-$0.6360,896,87260,896,872
2026-03-31$30.07M$41.37M-$41.37M$1.64M-$39.73M-$0.66-$0.6660,434,20060,434,200
2025-12-31$30.01M$39.28M-$39.28M$1.48M-$37.8M-$0.79-$0.79975,888975,888
2025-09-30$30.46M$38.73M-$38.73M$1.94M-$36.79M-$0.85-$0.8543,415,36743,415,367
2025-06-30$35.82M$44.41M-$44.41M$2.33M-$42.08M-$0.97-$0.9743,225,36543,225,365
2025-03-31$37.43M$47.41M-$47.41M$2.77M-$44.64M-$1.03-$1.0343,215,57743,215,577
2024-12-31$33.48M$41.04M-$41.04M$3.55M-$37.49M-$0.88-$0.881,632,3881,632,388
2024-09-30$29.19M$38.77M-$38.77M$4.28M-$34.49M-$0.80-$0.8043,155,85843,155,858
2024-06-30$27.32M$33.44M-$33.44M$4.63M-$28.8M-$0.67-$0.6743,125,70943,125,709
2024-03-31$22.48M$29.36M-$29.36M$2.67M-$26.69M-$1.12-$1.1223,754,06223,754,062
2023-12-31$17.16M$21.38M-$21.38M$710,000.00-$20.67M-$26.86-$26.8640,99840,998
2023-09-30$13.64M$16.28M-$16.28M$817,000.00-$15.47M-$23.27-$23.27664,656664,656
2023-06-30$10.41M$13.3M-$13.3M$211,000.00-$13.09M-$20.86-$20.86627,589627,589
2023-03-31$8.71M$11.45M-$11.45M$302,000.00-$11.14M-$12.10-$12.10921,260921,260

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$133.72M$169.83M-$169.83M$8.52M$0.00-$161.31M-$3.64-$3.6444,259,99944,259,999
2024-12-31$112.47M$142.6M-$142.6M$15.13M$0.00-$127.48M-$3.33-$3.3338,334,57138,334,571
2023-12-31$49.92M$62.41M-$62.41M$2.04M$0.00-$60.37M-$89.61-$89.61673,622673,622